NCT05887687View on ClinicalTrials.gov

68Ga-P3 PET/CT Imaging in Malignancy

NARecruitingINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Neoplasms

Interventions

DRUG

[68Ga]P3

68Ga-P3 is injected intravenously with a dose of 0.06-0.08 mCi/kg.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER